Perinodopril, an angiotensin converting enzyme inhibitor, attenuates experimental hepatic fibrosis

Human Platelet Rich Plasma Alleviates Liver Fibrosis in Murine Schistosomiasis Mansoni

Regulation of Liver Fibrosis during Murine Schistosomiasis Mansoni

Efficacy of Pentoxifylline as an Antifibrotic Drug in Experimental Murine Schistosomal Hepatic Fibrosis

Interferon-Α Immunotherapy, Combined with Praziquantel Downregulates VEGF Gene Expression, Causing Regression of Hepatic Fibrosis in Chronic Schistosoma Mansoni Experimental Infec

Blocking angiotensin pathway induces anti-fibrotic effects in a mouse model of schistosomiasis by decreasing egg burden and granulomatous reaction

Invasive and Non-Invasive Evaluation of antifibrotic effect of Losartan on Experimentally Induced Liver Fibrosis: A Biochemical and Histological Study

EFFICACY OF PENTOXIFYLLINE AS AN ANTIFIBROTIC DRUG IN EXPERIMENTAL MURINE SCHISTOSOMAL HEPATIC FIBROSIS

THE ANTIFIBROTIC POTENTIAL OF RESVERATROL IN SCHISTOSOMA MANSONI -INFECTED MICE

Pentoxifylline and/or praziquantel reduce murine schistosomiasis mansoni histopathology via amelioration of liver functions